Mauna Kea Technologies SA (FRA:1MK)

Market Cap	7.22M
Revenue (ttm)	8.18M
Net Income (ttm)	-10.39M
Shares Out	n/a
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	12,751
Open	0.0651
Previous Close	0.0655
Day's Range	0.0651 - 0.0651
52-Week Range	0.0423 - 0.2055
Beta	n/a
RSI	49.60
Earnings Date	Apr 23, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 65
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1MK

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.